Synopsys 10-Q 2025-01-31

Filed 2025-02-26. 8 sections, 303K characters. Original on sec.gov · Markdown · JSON

Cover and table of contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(MARK ONE)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2025

OR

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO

COMMISSION FILE NUMBER: 000-19807

synopsyslogoa20.jpg

SYNOPSYS, INC.

(Exact name of registrant as specified in its charter)

Delaware56-1546236
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)

675 ALMANOR AVE

SUNNYVALE, CA 94085

(Address of principal executive offices, including zip code)

(650) 584-5000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock (par value of $0.01 per share)SNPSNasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filerýAccelerated Filer☐
Non-accelerated filer¨Smaller reporting company☐
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý

As of February 24, 2025, there were 154,620,076 shares of the registrant’s common stock outstanding.

SYNOPSYS, INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE FISCAL QUARTER ENDED JANUARY 31, 2025

TABLE OF CONTENTS

Page
PART I.Financial Information1
Item 1.Financial Statements (Unaudited)1
Condensed Consolidated Balance Sheets1
Condensed Consolidated Statements of Income2
Condensed Consolidated Statements of Comprehensive Income3
Condensed Consolidated Statements of Stockholders’ Equity4
Condensed Consolidated Statements of Cash Flows5
Notes to Condensed Consolidated Financial Statements6
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations28
Item 3.Quantitative and Qualitative Disclosures About Market Risk42
Item 4.Controls and Procedures43
PART II.Other Information44
Item 1.Legal Proceedings44
Item 1A.Risk Factors45
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds63
Item 5.Other Information63
Item 6.Exhibits64
Signatures66

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

SYNOPSYS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands, except par value amounts)

January 31, 2025October 31, 2024
ASSETS
Current assets:
Cash and cash equivalents$3,653,880$3,896,532
Short-term investments155,489153,869
Total cash, cash equivalents and short-term investments3,809,3694,050,401
Accounts receivable, net892,647934,470
Inventories415,199361,849
Prepaid and other current assets1,206,4011,122,946
Total current assets6,323,6166,469,666
Property and equipment, net546,406563,006
Operating lease right-of-use assets, net545,867565,917
Goodwill3,433,3693,448,850
Intangible assets, net180,950195,164
Deferred income taxes1,393,0441,247,258
Other long-term assets617,837583,700
Total assets$13,041,089$13,073,561
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities$938,679$1,163,592
Operating lease liabilities99,31094,791
Deferred revenue1,320,6051,391,737
Total current liabilities2,358,5942,650,120
Long-term operating lease liabilities551,507574,065
Long-term deferred revenue316,178340,831
Long-term debt14,22015,601
Other long-term liabilities495,689469,738
Total liabilities3,736,1884,050,355
Redeemable non-controlling interest—30,000
Stockholders’ equity:
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding——
Common stock, $0.01 par value: 400,000 shares authorized; 154,618 and 154,112 shares outstanding, respectively1,5471,541
Capital in excess of par value1,127,1811,211,206
Retained earnings9,278,9508,984,105
Treasury stock, at cost: 2,643 and 3,148 shares, respectively(860,967)(1,025,770)
Accumulated other comprehensive income (loss)(241,919)(180,380)
Total Synopsys stockholders’ equity9,304,7928,990,702
Non-controlling interest1092,504
Total stockholders’ equity9,304,9018,993,206
Total liabilities, redeemable non-controlling interest and stockholders’ equity$13,041,089$13,073,561

See the accompanying Notes to Condensed Consolidated Financial Statements (unaudited).

SYNOPSYS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited, in thousands, except per share amounts)

Three Months Ended January 31,
20252024
Revenue:
Time-based products$828,238$805,063
Upfront products368,124442,366
Total products revenue1,196,3621,247,429
Maintenance and service258,953263,560
Total revenue1,455,3151,510,989
Cost of revenue:
Products168,842175,498
Maintenance and service92,53790,540
Amortization of acquired intangible assets8,59613,155
Total cost of revenue269,975279,193
Gross margin1,185,3401,231,796
Operating expenses:
Research and development553,216525,534
Sales and marketing209,199218,843
General and administrative167,086131,264
Amortization of acquired intangible assets4,0003,529
Total operating expenses933,501879,170
Operating income251,839352,626
Interest and other income (expense), net39,278104,828
Income before income taxes291,117457,454
Provision (benefit) for income taxes(6,294)22,909
Net income from continuing operations297,411434,545
Income from discontinued operations, net of income taxes—11,662
Net income297,411446,207
Less: Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest1,728(2,905)
Net income attributed to Synopsys$295,683$449,112
Net income attributed to Synopsys:
Continuing operations$295,683$437,450

Showing the first 8K of 130K characters. Open the full section

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q (this Quarterly Report) includes forward-looking statements, which involve risks, uncertainties and other factors that could cause Synopsys, Inc.'s (Synopsys, we, our or us) actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Readers are urged to carefully review and consider the various disclosures regarding these risks and uncertainties made in this Quarterly Report, including those identified below in Part II, Item 1A, Risk Factors, and in other documents we file from time to time with the Securities and Exchange Commission (SEC). Forward-looking statements include any statements that are not statements of historical fact and include, but are not limited to, statements concerning strategies related to our products, technology and services; business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence (AI); planned acquisitions and their expected impact, such as our pending acquisition of ANSYS, Inc. (Ansys), including, among other things, expectations regarding the financing of pending acquisitions; planned dispositions and their expected impact; the potential impact of the uncertain macroeconomic environment on our financial results, including, but not limited to, the effects of sustained global inflationary pressures and elevated interest rates, potential economic slowdowns or recessions, supply chain disruptions, geopolitical pressures, including, among others, the unknown impact of current and future U.S. and foreign trade regulations, government actions and regulatory changes, such as export control restrictions and tariffs, and regional or global military conflicts, and fluctuations in foreign exchange rates, and associated global economic conditions; customer demand and market expansion; our planned product releases and capabilities; industry growth rates; the expected realization of our contracted but unsatisfied or partially unsatisfied performance obligations (backlog); software trends; planned stock repurchases; our expected tax rate; and the impact and result of pending legal, administrative and tax proceedings. Forward-looking statements may be identified by words including, but not limited to, “may,” “will,” “could,” “would,” “can,” “should,” “anticipate,” “expect,” “intend,” “believe,” “estimate,” “project,” “continue,” “forecast,” "likely," "potential," "seek," or the negatives of such terms and similar expressions. The information included herein represents our estimates and assumptions as of the date of this filing. Unless required by law, we undertake no obligation to update publicly any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. All subsequent written or oral forward-looking statements attributable to Synopsys or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements.

The following summary and overview of our financial condition and results of operations are qualified in their entirety by the more complete discussions and should be read together with our condensed consolidated financial statements and the related notes thereto contained in Part I, Item 1 of this Quarterly Report, the risk factors set forth in Part II, Item 1A of this Quarterly Report, and with our audited consolidated financial statements and the related notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended October 31, 2024, as filed with the SEC on December 19, 2024 (our Annual Report).

Overview

Unless otherwise noted, this Management’s Discussion and Analysis of Financial Condition and Results of Operations relates solely to our continuing operations and does not include the operations of our former Software Integrity business. See “Software Integrity Divestiture” below and Note 3. Discontinued Operations of the Notes to Condensed Consolidated Financial Statements for additional information about the Software Integrity Divestiture.

Financial Performance Summary

For the first quarter of fiscal 2025, our results reflect continued strong execution, with our revenue and operating income reflecting a challenging comparison against the strength of our results and the impact of the extra week in the first quarter of fiscal 2024, as well as the timing of customer spending for hardware and IP and lower revenue in China in the first quarter of fiscal 2025. The following table sets forth some of our key quarterly unaudited financial information:

Three Months Ended January 31,
20252024
(in millions, except per share amounts)
Revenue$1,455.3$1,511.0
Cost of revenue$270.0$279.2
Operating expenses$933.5$879.2
Operating income$251.8$352.6
Net income from continuing operations attributed to Synopsys$295.7$437.5
Net income from discontinued operations attributed to Synopsys$—$11.7
Diluted net income per share attributed to Synopsys:
Continuing operations$1.89$2.82
Discontinued operations$—$0.07

Financial performance summary for the three months ended January 31, 2025 compared to the same period of fiscal 2024:

  • Revenues were $1.5 billion, a decrease of $55.7 million or 4%, primarily due to the impact of the extra week in the first quarter of fiscal 2024 of approximately $63.2 million, as well as a decrease in the revenue of IP and hardware products of approximately $74.0 million driven by the timing of customer spending and strong IP revenue in the first quarter of fiscal 2024.

  • Total cost of revenue and operating expenses was $1.2 billion, an increase of $45.1 million or 4%, primarily due to an increase of $34.4 million in legal, consulting and other professional fees mainly in connection with the Ansys Merger, and $27.1 million in employee-related costs resulting from headcount increases through organic growth and acquisitions.

  • Operating income was $251.8 million, a decrease of $100.8 million or 29%.

Business Summary

Synopsys delivers trusted and comprehensive silicon to systems design solutions, from EDA, including system verification and validation solutions, to silicon IP. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their engineering and research and development capacity. We are catalyzing the era of pervasive intelligence, powering innovation today that ignites the ingenuity of tomorrow. For more information about our business segments and product groups, se

Showing the first 8K of 68K characters. Open the full section

Item 3. Quantitative and Qualitative Disclosures About Market Risk

See Note 10. Bridge Commitment Letter, Term Loan and Revolving Credit Facilities of the Notes to Condensed Consolidated Financial Statements and Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in Part I of this Quarterly Report regarding borrowings under our Term Loan Agreement and Revolving Credit Agreement.

As of January 31, 2025, our exposure to market risk had not changed materially since November 2, 2024. For more information on financial market risks related to changes in interest rates and foreign currency rates, reference is made to Item 7A, Quantitative and Qualitative Disclosures About Market Risk contained in Part II of our Annual Report.

Item 4. Controls and Procedures

(a)Evaluation of Disclosure Controls and Procedures. As of January 31, 2025, Synopsys carried out an evaluation under the supervision and with the participation of Synopsys’ management, including the Chief Executive Officer (CEO) and Chief Financial Officer (CFO), of the effectiveness of the design and operation of Synopsys’ disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)). Regardless of how well designed and operated, there are inherent limitations to the effectiveness of any system of disclosure controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives. Our compliance programs and compliance training for employees may not prevent our employees or contractors from breaching or circumventing our policies or violating applicable laws and regulations. Our CEO and CFO have concluded that, as of January 31, 2025, Synopsys’ disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in the reports Synopsys files and submits under the Exchange Act is recorded, processed, summarized and reported as and when required, and that such information is accumulated and communicated to Synopsys’ management, including the CEO and CFO, to allow timely decisions regarding its required disclosure.

(b)Changes in Internal Control over Financial Reporting. There were no changes in Synopsys’ internal control over financial reporting during the fiscal quarter ended January 31, 2025 that have materially affected, or are reasonably likely to materially affect, Synopsys’ internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We are subject to routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate outcome of any litigation is often uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. Regardless of outcome, litigation can have an adverse impact on Synopsys because of the defense costs, diversion of management resources and other factors.

We regularly review the status of each significant matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount is estimable, we accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and as circumstances change, it is possible that the amount of any accrued liability may increase, decrease or be eliminated.

We are not aware of any legal proceedings that would materially impact our business, operating results or financial condition.

Item 1A. Risk Factors

Risk Factor Summary

Our business is subject to numerous risks and uncertainties. These risks include, but are not limited to, the following:

Industry Risks

*•*Uncertainty in the macroeconomic environment, and its potential impact on the semiconductor and electronics industries, may negatively affect our business, operating results and financial condition.

*•*The growth of our business depends primarily on the semiconductor and electronics industries.

*•*We operate in highly competitive industries, and if we do not continue to meet our customers’ demand for innovative technology at lower costs, our products may not be competitive or may become obsolete.

*•*We are subject to governmental export and import requirements that could subject us to liability and restrict our ability to sell our products and services, which could impair our ability to compete in international markets.

*•*Consolidation among our customers and within the industries in which we operate, as well as our dependence on a relatively small number of large customers, may negatively impact our operating results.

Business Operations Risks

*•*The global nature of our operations exposes us to increased risks and compliance obligations.

*•*Our operating results may fluctuate in the future, which may adversely affect our stock price.

*•*We may not realize the potential financial or strategic benefits of the transactions we complete, or find suitable target businesses and technology to acquire.

*•*Cybersecurity threats or other security breaches could compromise sensitive information belonging to us or our customers and could harm our business and our reputation.

*•*If we fail to protect our proprietary technology, our business will be harmed.

*•*We may not be successful in our AI initiatives, which could adversely affect our business, operating results or financial condition.

*•*If we fail to timely recruit and/or retain senior management and key employees globally, our business may be harmed.

*•*We may pursue new product and technology initiatives or expand into adjacent markets, and if we fail to successfully carry out these initiatives, we could be adversely impacted.

*•*We may have to invest more resources in research and development than anticipated, which could increase our operating expenses and negatively affect our operating results.

*•*Product errors or defects could expose us to liability and harm our reputation and we could lose market share.

*•*Our hardware products, which primarily consist of prototyping and emulation systems, subject us to distinct risks.

*•*From time to time, we are subject to claims that our products infringe on third-party intellectual property rights.

*•*We may not be able to continue to obtain licenses to third-party software and intellectual property on reasonable terms or at all, which may disrupt our business and harm our financial results.

*•*Liquidity requirements in our U.S. operations may require us to raise cash in uncertain capital markets, which could negatively affect our financial condition.

Risks Related to the Ansys Merger

*•*We may fail to complete the Ansys Merger or may not complete it on the terms described herein or in our other filings with the SEC.

*•*The Ansys Merger is subject to the receipt of governmental approvals that may impose conditions that could have an adverse effect on us or, if not obtained, could prevent completion of the Ansys Merger.

*•*Failure to realize the benefits expected from the Ansys Merger could adversely affect our business, operating results and financial condition.

*•*As a result of the Ansys Merger, we anticipate that the scope and size of our operations and business will substantially change and will result in certain incremental risks to us, including increased competition. We may not realize the full expected benefits of the Ansys Merger.

*•*Our significant debt may limit our financial flexibility following the Ansys Merger.

*•*The covenants contained in the agreements governing our indebtedness following the Ansys Merger may impose restrictions on us and certain of our subsidiaries that may affect our ability to operate our businesses.

Legal and Regulatory Risks

*•*Changes in tax laws and regulations or interpretations thereof, or any change in the application of existing laws and regulations may adversely affect our effective tax rates and financial results.

*•*Our business is subject to evolving corporate governance and public disclosure regulations and expectations that could expose us to numerous risks.

*•*We may be subject to litigation proceedings that could harm our business.

General Risks

*•*Catastrophic events and the effects of climate change, pandemics or other unexpected events may disrupt our business and harm our operating results.

Factors that May Affect Future Results

Descriptions of risks associated with our business are set forth below. Some of these risks are highlighted in the following discussion and in Management's Discussion and Analysis of Financial Condition and Results of Operations, Legal Proceedings, Controls and Procedures and Quantitative and Qualitative Disclosures About Market Risk of this Quarterly Report. The occurrence of any of these risks or additional risks and uncertainties not presently known to us or that we currently believe to be immaterial could materially and adversely affect our business, financial condition, operating results and stock price. These risks and uncertainties could cause our actual results to differ materially from the results contemplated by the forward-looking statements contained in this Quarterly Report. Investors should carefully consider all relevant risks before investing in our common stock.

Industry Risks

Uncertainty in the macroeconomic environment, and its potential impact on the semiconductor and electronics industries, may negatively affect our business, operating results and financial condition.

Uncertainty in the macroeconomic environment, including the effects of, among other things, sustained global inflationary pressures and elevated interest rates, potential economic slowdowns or recessions, supply chain disruptions, geopolitical pressures, fluctuations in foreign exchange rates and associated global economic conditions, have resulted in volatility in credit, equity and foreign currency markets. This uncertain macroeconomic environment has led some of our customers to postpone their decision-making, delay their drawdowns under non-cancellable commitments, decrease their spending and/or delay their payments to us. Such caution by customers has, among other things, limited our ability to maintain or increase our sales or recognize revenue from committed contracts.

If these macroeconomic uncertainties persist and economic conditions continue to deteriorate, then the semiconductor and electronics industries could fail to grow. Additionally, uncertain macroeconomic conditions could also have the effect of increasing other risks and uncertainties facing our business, which could have a material adverse effect on our operating results and financial condition. Such risks that may be heightened by uncertain macroeconomic conditions include China’s stated policy of becoming a global leader in the semiconductor industry, which may lead to increased competition or further disruption of international trade relationships, including, but not limited to, additional government trade restrictions. For more on risks related to government export and import restrictions, see “We are subject to governmental export and import requirements that could subject us to liability and restrict our ability to sell our products and services, which could impair our ability to compete in international markets.”

Adverse economic conditions affect demand for devices that our products help create, such as the IC

Showing the first 8K of 87K characters. Open the full section

Item 5. Other Information

Insider Adoption or Termination of Trading Arrangements

None of our directors or officers informed us of the adoption, modification or termination of a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as those terms are defined in Item 408(c) of Regulation S-K) during the quarterly period covered by this report, except as described in the table below:

Name and TitleActionDate AdoptedCharacter of Trading Arrangement**(1)**Aggregate Number of Common Stock to be Purchased or Sold Pursuant to Trading ArrangementExpiration Date**(2)(3)**
Shelagh GlaserAdoption1/13/2025Rule 10b5-1 Trading ArrangementUp to 14,622 shares to be sold12/12/2025
Chief Financial Officer

*(1)*Except as indicated by footnote, each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended (the Rule).

*(2)*Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permitted or only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.

*(3)*The trading arrangement also provides for automatic expiration upon notice from the officer of termination of the trading arrangement.

Item 6. Exhibits

Exhibit NumberIncorporated By ReferenceFiled Herewith
Exhibit DescriptionFormFile No.ExhibitFiling Date
2.1Agreement and Plan of Merger, dated as of January 15, 2024, by and among Synopsys, Inc., ANSYS, Inc. and ALTA Acquisition Corp.8-K000-198072.11/16/2024
3.1Amended and Restated Certificate of Incorporation10-Q000-198073.19/15/2003
3.2Amended and Restated Bylaws8-K000-198073.13/25/2024
4.1Specimen Common Stock CertificateS-133-451384.32/24/1992 (effective date)
31.1Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange ActX
31.2Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange ActX
32.1*Certification of Chief Executive Officer and Chief Financial Officer furnished pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States CodeX
101The following financial statements from Synopsys' Quarterly Report on Form 10-Q for the quarter ended January 31, 2025, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets as of January 31, 2025 and November 2, 2024, (ii) Condensed Consolidated Statements of Income for the Three Months Ended January 31, 2025 and February 3, 2024, (iii) Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended January 31, 2025 and February 3, 2024, (iv) Condensed Consolidated Statements of Stockholders' Equity at January 31, 2025 and February 3, 2024, (v) Condensed Consolidated Statements of Cash Flows for the Three Months Ended January 31, 2025 and February 3, 2024 and (vi) the Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tagsX
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
  • This exhibit is furnished with this Quarterly Report and is not deemed filed with the Securities and Exchange Commission and is not incorporated by reference in any filing of Synopsys, Inc. under the Securities Act of 1933, as

amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language contained in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned thereunto duly authorized.

SYNOPSYS, INC.
Date: February 26, 2025By:/s/ SHELAGH GLASER
Shelagh Glaser Chief Financial Officer (Principal Financial Officer)